MBMustansir Bhori

Mustansir Bhori

*This is an algorithmically generated author record based on publicly available information.

Mustansir Bhori has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nutraceuticals Explored

    by Mustansir Bhori, Ameyota De, Shreya Das, Vaishnavi Kesarkar, Aayushi Kadam, Kanchanlata Tungare

    A nutraceutical is a food with additional health advantages beyond its basic nutritional content that helps in the prevention and treatment of disease(s) and other disorders (excluding anaemia). Due to their potential for having nutritional, safe, and therapeutic impacts, nutraceuticals have recently attracted a lot of attention. Concerning metabolic syndrome, the size of the global nutraceuticals market has expanded and is estimated to flourish between 2022 and 2030. This is because of its easy availability, easy access, tolerability, and cost-effectiveness, nevertheless considering the broad range of safety. Previous studies have reported that it has been proven that the majority of nutraceuticals have antioxidant activity that can help prevent adverse conditions. Hence, they are regarded as beneficial sources for promoting health, particularly in terms of preventing fatal diseases like diabetes, infections, renal disorders, and gastrointestinal disorders. However, some nutraceuticals are safe, while others do possess toxic potential. There are a large number of nutraceuticals for which toxicity and safety data are not available, owing to a lack of clinical trials, and pharmacological and toxicological studies. Some nutraceuticals’ safety may be jeopardised by contamination with poisonous organisms, metals, mycotoxins, illicit drugs, etc. Despite their popularity, the health benefits of dietary supplements are questionable. Compared to pharmaceuticals, nutraceuticals’ toxic characteristics have not been thoroughly investigated. In actuality, the argument that dietary supplements and nutraceuticals are harmful is weak. Therefore, we thoroughly study the toxic characteristics of nutraceuticals in this chapter and draw a conclusion in it.


  • Biogenic Synthesis of Nanomaterials Using Diverse Microbial Nano-Factories

    by Kanchanlata Tungare, Priyamvada Arte, Aqdas Khan, Khadija Turabi, Renitta Jobby, Mustansir Bhori


  • Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach

    by Priyamvada Amol Arte, Kanchanlata Tungare, Mustansir Bhori, Renitta Jobby, Jyotirmoi Aich

    Type 2 Diabetes Mellitus (T2DM) accounts for more than 90% of total diabetes mellitus cases all over the world. Obesity and lack of balance between energy intake and energy expenditure are closely linked to T2DM. Initial pharmaceutical treatment and lifestyle interventions can at times lead to remission but usually help alleviate it to a certain extent and the condition remains, thus, recurrent with the patient being permanently pharmaco-dependent. Mesenchymal stromal cells (MSCs) are multipotent, self-renewing cells with the ability to secrete a variety of biological factors that can help restore and repair injured tissues. MSC-derived exosomes possess these properties of the original stem cells and are potentially able to confer superior effects due to advanced cell-to-cell signaling and the presence of stem cell-specific miRNAs. On the other hand, the repository of antidiabetic agents is constantly updated with novel T2DM disease-modifying drugs, with higher efficacy and increasingly convenient delivery protocols. Delving deeply, this review details the latest progress and ongoing studies related to the amalgamation of stem cells and antidiabetic drugs, establishing how this harmonized approach can exert superior effects in the management and potential reversal of T2DM.


  • Phytochemical content and antioxidant activity of different varieties of Stevia rebaudiana

    by Rinkey Shahu, Renitta Jobby, Swaroopa Patil, Mustansir Bhori, Kanchanlata Tungare, Pamela Jha


  • Dietary Polyphenols in Bacterial and Fungal Infections

    by Veda Joshi, Swarangi Tambat, Mustansir Bhori, Jyotirmoi Aich, Kanchanlata Tungare

    The ever-increasing global disease burden continually draws the attention of the scientific community to novel therapeutics and their promising beneficial effects. Profound results of many studies have confirmed the superiority and prolificity of natural compounds over conventional synthetic drugs. The scientific endeavors to discover the various health benefits of dietary polyphenols have investigated its potent effects in many diseases and conditions, as opposed to most of the artificially synthesized drugs that bring about a specific effect. Recent efforts in understanding the plausible equivalents of drug candidates have uncovered the phenomenal properties and diverse varieties of dietary polyphenols that are available in abundance in our daily diet. This chapter elucidates the different classes, structural and physiological properties of dietary polyphenols with justification for their diverse nature and therapeutic effects. Current research on polyphenols has revealed their antibacterial and antifungal properties much to the rescue of mankind. The omnipresence of both the pathogens, complex structures, high virulence, and intricate mechanisms of infection makes it difficult to design an ideal multi-faceted drug. Furthermore, the acquisition of drug resistance and genetic mutations helps these pathogens to escape the deleterious effects of several drugs. Unlike conventional drug formulations, polyphenols act through numerous mechanisms by targeting multiple cellular machinery and interfering in the major metabolic pathways of these microbes. Polyphenols, by virtue of their heterogeneous nature of synergistic and immunomodulatory mechanisms, qualify as among the most suitable nutraceuticals that have immense potential to act against infections.

  • Anti-Cancer Phytopharmaceuticals

    by Priyanka Mudaliar, Apoorva Jagannath Nalawade, Priyamvada Arte, Akanksha Dhuliya, Deepak Iyer, Kanchanlata Tungare, Mustansir Bhori, Jyotirmoi Aich

    Cancer is among the world’s most severe health concerns, with escalating prevalence. Though there has been remarkable evolvement in the treatment and management of cancer growth, there are still flaws and space for improvements. The need for cytotoxic agents is still an important field of research in the development of current anticancer medications. Many novel marketed cancer treatments have been either derived from natural sources, through structural alteration of native compounds, or by the synthesis of new compounds based on a natural component as a model. Exploration and harnessing nature, particularly for the discovery of new anticancer medicines, is a boon in the search for new and better pharmaceuticals. Herbs continue to be an important source of many clinically effective anticancer drugs used around the world, and many of them have been identified and are in clinical trials. The current chapter covers the most recent findings in cancer prevention and treatment using phytochemical constituents from plant sources, with a focus on plant-derived organic chemicals that have shown great potential as anticancer agents in recent years, with their respective mechanism of action, development challenges and opportunities.

  • Open Access

    Assessment of attitudes and practices regarding oral healthcare during the COVID-19 pandemic among the parents of children aged 4–7 years

    by Indu Varkey, Kiran Ghule, Robin Mathew, Jinal Desai, Sheiba Gomes, Akshaya Mudaliar, Mustansir Bhori, Kanchanlata Tungare, Adveta Gharat

    Background. The coronavirus disease 2019 (COVID-19) pandemic has brought about radical changes in our habits and lifestyles. The suspension of schools has led children to spend long hours at home, with reduced socialization, and changes in dietary patterns, oral hygiene practices and sleep routines. During a pandemic, appropriate oral health management and disease prevention are very important for the child's oral and general health.Objectives. The aim of this study was to assess the attitudes and practices of parents with regard to their children's oral healthcare, dietary habits and dental care during the COVID-19 pandemic. Material and methods. This cross-sectional study included 381 Indian parents of children aged 4-7 years. A self-instructed questionnaire was designed in English using the Google Forms platform. The questionnaire consisted of 4 parts: sociodemographic data; dietary habits of the child; oral hygiene measures; and dental information. The collected data was analyzed using descriptive and analytical statistics (the chi 2 test).Results. Among the children included in the study, 48% of those who experienced dental problems during the pandemic consumed more snacks and packaged foods between meals. Among the parents, 80% reported that their children used electronic devices at mealtimes, and 60% reported the food pouching habit in their children. A total of 71% of parents assisted their child at tooth brushing, while only 28% of the parents would take their child to the dental clinic for treatment.Conclusions. This study highlights the shortfalls in attitudes and practices among parents in relation to dietary habits, oral hygiene measures and the use of dental services during the COVID-19 pandemic regarding their children. This could be attributed to a lack of awareness, the fear of exposure and the incon-veniences faced by parents.


  • Milk-derived multi-fluorescent graphene quantum dot-based cancer theranostic system

    by Mukeshchand Thakur, Ashmi Mewada, Sunil Pandey, Mustansir Bhori, Kanchanlata Singh, Maheshwar Sharon, Madhuri Sharon